You are using an outdated browser. For a faster, safer browsing experience, upgrade for free today.

Medical Care

Global Osteoarthritis Pain Drugs Market Analysis 2016-2020 and Forecast 2021-2026

Snapshot

The global Osteoarthritis Pain Drugs market size is estimated at xxx million USD with a CAGR xx% from 2016-2020 and is expected to reach xxx Million USD in 2021 with a CAGR xx% from 2021 to 2026. The report begins from overview of Industry Chain structure, and describes industry environment, then analyses market size and forecast of Osteoarthritis Pain Drugs by product, region and application, in addition, this report introduces market competition situation among the vendors and company profile, besides, market price analysis and value chain features are covered in this report.

Product Type Coverage (Market Size & Forecast, Major Company of Product Type etc.):
Oral
Injection
External

Company Coverage (Company Profile, Sales Revenue, Price, Gross Margin, Main Products etc.):
Abbott Laboratories
Johnson & Johnson
Novartis International
Pfizer
Abiogen Pharma
Afferent Pharmaceuticals
Astellas Pharma
BioDelivery Sciences International
Crystal Genomics
Cytori Therapeutics
Daiichi Sankyo
Eli Lilly
Endo Pharmaceuticals Holdings
Horizon Pharma
ICeutica
Iroko Pharmaceuticals
Merck
Nuvo Research
Regeneron Pharmaceuticals
Sanofi
SantoSolve
Techfields Pharma
Winston Pharmaceuticals
Yooyoung Pharmaceutical
Zynerba Pharmaceuticals

Application Coverage (Market Size & Forecast, Different Demand Market by Region, Main Consumer Profile etc.):
Hospitals
Clinics
Others

Region Coverage (Regional Production, Demand & Forecast by Countries etc.):
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Table of Contents
Table of Contents
1 Industry Overview
1.1 Osteoarthritis Pain Drugs Industry
Figure Osteoarthritis Pain Drugs Industry Chain Structure
1.1.1 Overview
1.1.2 Development of Osteoarthritis Pain Drugs
1.2 Market Segment
1.2.1 Upstream
Table Upstream Segment of Osteoarthritis Pain Drugs
1.2.2 Downstream
Table Application Segment of Osteoarthritis Pain Drugs
Table Global Osteoarthritis Pain Drugs Market 2016-2026, by Application, in USD Million
1.2.3 COVID-19 Impact
1.3 Cost Analysis
2 Industry Environment (PEST Analysis)
2.1 Policy
2.2 Economics
2.3 Sociology
2.4 Technology
3 Osteoarthritis Pain Drugs Market by Type
3.1 By Type
3.1.1 Oral
Table Major Company List of Oral
3.1.2 Injection
Table Major Company List of Injection
3.1.3 External
Table Major Company List of External
3.2 Market Size
Table Global Osteoarthritis Pain Drugs Market 2016-2020, by Type, in USD Million
Figure Global Osteoarthritis Pain Drugs Market Growth 2016-2020, by Type, in USD Million
Table Global Osteoarthritis Pain Drugs Market 2016-2020, by Type, in Volume
Figure Global Osteoarthritis Pain Drugs Market Growth 2016-2020, by Type, in Volume
3.3 Market Forecast
Table Global Osteoarthritis Pain Drugs Market Forecast 2021-2026, by Type, in USD Million
Table Global Osteoarthritis Pain Drugs Market Forecast 2021-2026, by Type, in Volume
4 Major Companies List
4.1 Abbott Laboratories (Company Profile, Sales Data etc.)
4.1.1 Abbott Laboratories Profile
Table Abbott Laboratories Overview List
4.1.2 Abbott Laboratories Products & Services
4.1.3 Abbott Laboratories Business Operation Conditions
Table Business Operation of Abbott Laboratories (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.2 Johnson & Johnson (Company Profile, Sales Data etc.)
4.2.1 Johnson & Johnson Profile
Table Johnson & Johnson Overview List
4.2.2 Johnson & Johnson Products & Services
4.2.3 Johnson & Johnson Business Operation Conditions
Table Business Operation of Johnson & Johnson (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.3 Novartis International (Company Profile, Sales Data etc.)
4.3.1 Novartis International Profile
Table Novartis International Overview List
4.3.2 Novartis International Products & Services
4.3.3 Novartis International Business Operation Conditions
Table Business Operation of Novartis International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.4 Pfizer (Company Profile, Sales Data etc.)
4.4.1 Pfizer Profile
Table Pfizer Overview List
4.4.2 Pfizer Products & Services
4.4.3 Pfizer Business Operation Conditions
Table Business Operation of Pfizer (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.5 Abiogen Pharma (Company Profile, Sales Data etc.)
4.5.1 Abiogen Pharma Profile
Table Abiogen Pharma Overview List
4.5.2 Abiogen Pharma Products & Services
4.5.3 Abiogen Pharma Business Operation Conditions
Table Business Operation of Abiogen Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.6 Afferent Pharmaceuticals (Company Profile, Sales Data etc.)
4.6.1 Afferent Pharmaceuticals Profile
Table Afferent Pharmaceuticals Overview List
4.6.2 Afferent Pharmaceuticals Products & Services
4.6.3 Afferent Pharmaceuticals Business Operation Conditions
Table Business Operation of Afferent Pharmaceuticals (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.7 Astellas Pharma (Company Profile, Sales Data etc.)
4.7.1 Astellas Pharma Profile
Table Astellas Pharma Overview List
4.7.2 Astellas Pharma Products & Services
4.7.3 Astellas Pharma Business Operation Conditions
Table Business Operation of Astellas Pharma (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.8 BioDelivery Sciences International (Company Profile, Sales Data etc.)
4.8.1 BioDelivery Sciences International Profile
Table BioDelivery Sciences International Overview List
4.8.2 BioDelivery Sciences International Products & Services
4.8.3 BioDelivery Sciences International Business Operation Conditions
Table Business Operation of BioDelivery Sciences International (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.9 Crystal Genomics (Company Profile, Sales Data etc.)
4.9.1 Crystal Genomics Profile
Table Crystal Genomics Overview List
4.9.2 Crystal Genomics Products & Services
4.9.3 Crystal Genomics Business Operation Conditions
Table Business Operation of Crystal Genomics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.10 Cytori Therapeutics (Company Profile, Sales Data etc.)
4.10.1 Cytori Therapeutics Profile
Table Cytori Therapeutics Overview List
4.10.2 Cytori Therapeutics Products & Services
4.10.3 Cytori Therapeutics Business Operation Conditions
Table Business Operation of Cytori Therapeutics (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.11 Daiichi Sankyo (Company Profile, Sales Data etc.)
4.11.1 Daiichi Sankyo Profile
Table Daiichi Sankyo Overview List
4.11.2 Daiichi Sankyo Products & Services
4.11.3 Daiichi Sankyo Business Operation Conditions
Table Business Operation of Daiichi Sankyo (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.12 Eli Lilly (Company Profile, Sales Data etc.)
4.12.1 Eli Lilly Profile
Table Eli Lilly Overview List
4.12.2 Eli Lilly Products & Services
4.12.3 Eli Lilly Business Operation Conditions
Table Business Operation of Eli Lilly (Sales Revenue, Cost, Gross Margin)
4.13 Endo Pharmaceuticals Holdings (Company Profile, Sales Data etc.)
4.13.1 Endo Pharmaceuticals Holdings Profile
Table Endo Pharmaceuticals Holdings Overview List
4.13.2 Endo Pharmaceuticals Holdings Products & Services
4.13.3 Endo Pharmaceuticals Holdings Business Operation Conditions
Table Business Operation of Endo Pharmaceuticals Holdings (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
4.14 Horizon Pharma (Company Profile, Sales Data etc.)
4.14.1 Horizon Pharma Profile
Table Horizon Pharma Overview List
4.14.2 Horizon Pharma Products & Services
4.14.3 Horizon Pharma Business Operation Conditions
Table Business Operation of Horizon Pharma (Sales Revenue, Cost, Gross Margin)
4.15 ICeutica (Company Profile, Sales Data etc.)
4.15.1 ICeutica Profile
Table ICeutica Overview List
4.15.2 ICeutica Products & Services
4.15.3 ICeutica Business Operation Conditions
Table Business Operation of ICeutica (Sales Revenue, Cost, Gross Margin)
4.16 Iroko Pharmaceuticals (Company Profile, Sales Data etc.)
4.16.1 Iroko Pharmaceuticals Profile
Table Iroko Pharmaceuticals Overview List
4.16.2 Iroko Pharmaceuticals Products & Services
4.16.3 Iroko Pharmaceuticals Business Operation Conditions
Table Business Operation of Iroko Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.17 Merck (Company Profile, Sales Data etc.)
4.17.1 Merck Profile
Table Merck Overview List
4.17.2 Merck Products & Services
4.17.3 Merck Business Operation Conditions
Table Business Operation of Merck (Sales Revenue, Cost, Gross Margin)
4.18 Nuvo Research (Company Profile, Sales Data etc.)
4.18.1 Nuvo Research Profile
Table Nuvo Research Overview List
4.18.2 Nuvo Research Products & Services
4.18.3 Nuvo Research Business Operation Conditions
Table Business Operation of Nuvo Research (Sales Revenue, Cost, Gross Margin)
4.19 Regeneron Pharmaceuticals (Company Profile, Sales Data etc.)
4.19.1 Regeneron Pharmaceuticals Profile
Table Regeneron Pharmaceuticals Overview List
4.19.2 Regeneron Pharmaceuticals Products & Services
4.19.3 Regeneron Pharmaceuticals Business Operation Conditions
Table Business Operation of Regeneron Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.20 Sanofi (Company Profile, Sales Data etc.)
4.20.1 Sanofi Profile
Table Sanofi Overview List
4.20.2 Sanofi Products & Services
4.20.3 Sanofi Business Operation Conditions
Table Business Operation of Sanofi (Sales Revenue, Cost, Gross Margin)
4.21 SantoSolve (Company Profile, Sales Data etc.)
4.21.1 SantoSolve Profile
Table SantoSolve Overview List
4.21.2 SantoSolve Products & Services
4.21.3 SantoSolve Business Operation Conditions
Table Business Operation of SantoSolve (Sales Revenue, Cost, Gross Margin)
4.22 Techfields Pharma (Company Profile, Sales Data etc.)
4.22.1 Techfields Pharma Profile
Table Techfields Pharma Overview List
4.22.2 Techfields Pharma Products & Services
4.22.3 Techfields Pharma Business Operation Conditions
Table Business Operation of Techfields Pharma (Sales Revenue, Cost, Gross Margin)
4.23 Winston Pharmaceuticals (Company Profile, Sales Data etc.)
4.23.1 Winston Pharmaceuticals Profile
Table Winston Pharmaceuticals Overview List
4.23.2 Winston Pharmaceuticals Products & Services
4.23.3 Winston Pharmaceuticals Business Operation Conditions
Table Business Operation of Winston Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
4.24 Yooyoung Pharmaceutical (Company Profile, Sales Data etc.)
4.24.1 Yooyoung Pharmaceutical Profile
Table Yooyoung Pharmaceutical Overview List
4.24.2 Yooyoung Pharmaceutical Products & Services
4.24.3 Yooyoung Pharmaceutical Business Operation Conditions
Table Business Operation of Yooyoung Pharmaceutical (Sales Revenue, Cost, Gross Margin)
4.25 Zynerba Pharmaceuticals (Company Profile, Sales Data etc.)
4.25.1 Zynerba Pharmaceuticals Profile
Table Zynerba Pharmaceuticals Overview List
4.25.2 Zynerba Pharmaceuticals Products & Services
4.25.3 Zynerba Pharmaceuticals Business Operation Conditions
Table Business Operation of Zynerba Pharmaceuticals (Sales Revenue, Cost, Gross Margin)
5 Market Competition
5.1 Company Competition
Table Global Osteoarthritis Pain Drugs Sales Revenue 2016-2020, by Company, in USD Million
Table Global Osteoarthritis Pain Drugs Sales Revenue Share 2016-2020, by Company, in USD Million
Figure Global Osteoarthritis Pain Drugs Sales Revenue Share in 2020, by Company, in USD Million
Table Global Osteoarthritis Pain Drugs Sales Volume 2016-2020, by Company, in Volume
Table Global Osteoarthritis Pain Drugs Sales Volume Share 2016-2020, by Company, in Volume
Figure Global Osteoarthritis Pain Drugs Sales Volume Share in 2020, by Company, in Volume
5.2 Regional Market by Company
Figure North America Osteoarthritis Pain Drugs Market Concentration, in 2020
Figure Europe Osteoarthritis Pain Drugs Market Market Concentration, in 2020
Figure Asia-Pacific Osteoarthritis Pain Drugs MMarket Concentration, in 2020
Figure South America Osteoarthritis Pain Drugs Market Concentration, in 2020
Figure Middle East & Africa Osteoarthritis Pain Drugs Market Concentration, in 2020
6 Demand by End Market
6.1 Demand Situation
6.1.1 Demand in Hospitals
Figure Osteoarthritis Pain Drugs Demand in Hospitals, 2016-2020, in USD Million
Figure Osteoarthritis Pain Drugs Demand in Hospitals, 2016-2020, in Volume
6.1.2 Demand in Clinics
Figure Osteoarthritis Pain Drugs Demand in Clinics, 2016-2020, in USD Million
Figure Osteoarthritis Pain Drugs Demand in Clinics, 2016-2020, in Volume
6.1.3 Demand in Others
Figure Osteoarthritis Pain Drugs Demand in Others, 2016-2020, in USD Million
Figure Osteoarthritis Pain Drugs Demand in Others, 2016-2020, in Volume
6.2 Regional Demand Comparison
Table Regional Demand Comparison List
Table Major Application in Different Regions
6.3 Demand Forecast
Table Osteoarthritis Pain Drugs Demand Forecast 2021-2026, by Application, in USD Million
Figure Osteoarthritis Pain Drugs Market Growth 2021-2026, by Application, in USD Million
Figure Osteoarthritis Pain Drugs Market Share in 2026, by Application, in USD Million
Table Osteoarthritis Pain Drugs Demand Forecast 2021-2026, by Application, in Volume
Table Osteoarthritis Pain Drugs Market Growth 2021-2026, by Application, in Volume
Table Osteoarthritis Pain Drugs Market Share in 2026, by Application, in Volume
6.4 Impact of the COVID-19 on the Demand
7 Region Operation
7.1 Regional Production
Table Osteoarthritis Pain Drugs Production 2016-2020, by Region, in USD Million
Table Osteoarthritis Pain Drugs Production 2016-2020, by Region, in Volume
7.2 Regional Market
Table Global Osteoarthritis Pain Drugs Market 2016-2020, by Region, in USD Million
Table Global Osteoarthritis Pain Drugs Market Share 2016-2020, by Region, in USD Million
Table Global Osteoarthritis Pain Drugs Market 2016-2020, by Region, in Volume
Table Global Osteoarthritis Pain Drugs Market Share 2016-2020, by Region, in Volume
7.3 by Region
7.3.1 North America
7.3.1.1 Overview
Figure North America Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in USD Million
Figure North America Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in Volume
7.3.1.2 by Country (U.S., Canada, Mexico)
Table North America Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in USD Million
Table North America Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in Volume
7.3.2 Europe
7.3.2.1 Overview
Figure Europe Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in USD Million
Figure Europe Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in Volume
7.3.2.2 by Country (Germany, U.K., France, Italy, Russia, Spain etc.)
Table Europe Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in USD Million
Table Europe Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in Volume
7.3.3 Asia-Pacific
7.3.3.1 Overview
Figure Asia-Pacific Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in USD Million
Figure Asia-Pacific Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in Volume
7.3.3.2 by Country (China, India, Japan, Southeast Asia etc.)
Table Asia-Pacific Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in USD Million
Table Asia-Pacific Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in Volume
7.3.4 South America
7.3.4.1 Overview
Figure South America Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in USD Million
Figure South America Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in Volume
7.3.4.2 by Country (Brazil, Argentina etc.)
Table South America Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in USD Million
Table South America Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in Volume
7.3.5 Middle East & Africa
7.3.5.1 Overview
Figure Middle East & Africa Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in USD Million
Figure Middle East & Africa Osteoarthritis Pain Drugs Market Size and Growth 2016-2020, in Volume
7.3.5.2 by Country (Saudi Arabia, South Africa etc.)
Table Middle East & Africa Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in USD Million
Table Middle East & Africa Osteoarthritis Pain Drugs Market Size 2016-2020, by Country, in Volume
7.4 Regional Import & Export
7.5 Regional Forecast
Table Osteoarthritis Pain Drugs Market Forecast 2021-2026, by Region, in USD Million
Table Osteoarthritis Pain Drugs Market Forecast 2021-2026, by Region, in Volume
8 Marketing & Price
8.1 Price and Margin
8.1.1 Price Trends
8.1.2 Factors of Price Change
Table Price Factors List
8.1.3 Manufacturers Gross Margin Analysis
8.2 Marketing Channel
Figure Marketing Channels Overview
9 Research Conclusion
  • FORMAT: PDF
  • PUBLISHED DATE: Apr, 2021
  • NO OF PAGES: 127